For over three decades, Horgen Med has been at the forefront of clinical research innovation, delivering high-quality, reliable, and efficient solutions. As a full-service CRO, we have partnered with global organizations to advance life-changing therapies through precision-driven trials and cutting-edge methodologies. Our commitment to scientific excellence, regulatory compliance, and patient-focused research has made us a trusted name in the industry.
At Horgen Med, we understand that the heart of every successful clinical trial lies in robust, accurate, and insightful data analysis. Our Biostatistics services are designed to transform complex data into actionable insights, driving your research forward with confidence and precision.
Explore More
Our Clinical Safety & Pharmacovigilance services are designed to safeguard participants in clinical trials and ensure the ongoing safety of marketed products. With a proactive, comprehensive approach, we help you identify, assess, and mitigate risks, ensuring compliance with global regulatory standards and fostering trust in your therapies.
Explore More
Our Medical Monitoring services provide vigilant, end-to-end oversight of your study, ensuring protocols are followed, risks are mitigated, and patient well-being remains paramount.
Explore More
At the forefront of these efforts is Horgen Med, a pioneering research institution dedicated to combating infectious diseases. Through cutting-edge research, strategic collaborations with leading pharmaceutical companies, and innovative vaccine development, Horgen Med has played a vital role in the advancement of polio research.
+ Read More
At the forefront of this groundbreaking development is Horgen Med, a leader in ALS research and innovation. Through rigorous clinical studies, strategic collaborations, and a commitment to pushing the boundaries of medical science, Horgen Med has played a crucial role in bringing Albrioza from research to reality.
+ Read More
Horgen Med played a critical role in the research, development, and clinical trials that led to the approval of Riluzole. Through a strategic partnership with Sanofi, a global pharmaceutical leader, Horgen Med helped bring this groundbreaking treatment to patients worldwide.
+ Read More